MoneyWorks4Me

The company witnessed a 14.55% growth in the revenue at Rs. 186.24 millions for the quarter ended June 2025 as compared to Rs. 162.58 millions during the year-ago period.A humble growth in net profit of 16.59% reported in the quarter ended June 2025 to Rs. 18.27  millions from Rs. 15.67 millions.Operating profit surged to 26.62 millions from the corresponding previous quarter of 23.43 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 186.24 162.58 14.55 186.24 162.58 14.55 665.08 858.31 -22.51
Other Income 5.46 3.76 45.21 5.46 3.76 45.21 18.39 15.81 16.32
PBIDT 26.62 23.43 13.62 26.62 23.43 13.62 134.46 140.09 -4.02
Interest 0.05 0.23 -78.26 0.05 0.23 -78.26 0.73 1.81 -59.67
PBDT 26.57 23.20 14.53 26.57 23.20 14.53 133.73 138.28 -3.29
Depreciation 2.16 2.25 -4.00 2.16 2.25 -4.00 9.05 5.75 57.39
PBT 24.41 20.95 16.52 24.41 20.95 16.52 124.68 132.53 -5.92
TAX 6.14 5.28 16.29 6.14 5.28 16.29 31.94 33.84 -5.61
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 6.50 4.39 48.06
PAT 18.27 15.67 16.59 18.27 15.67 16.59 92.74 98.69 -6.03
Equity 57.57 57.57 0.00 57.57 57.57 0.00 57.57 57.57 0.00
PBIDTM(%) 14.29 14.41 -0.82 14.29 14.41 -0.82 20.22 16.32 23.87
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..